http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5318910-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af4b763a46df1ce6c323b97af0273241
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-106664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-102499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
filingDate 1993-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9add1030cf1d267c58f833b3c577031b
publicationDate 1994-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5318910-A
titleOfInvention Standard whole blood composition for determining the potency of blood clotting inhibitory substances
abstract A standard whole blood composition is disclosed, which is useful as a pooled human hemostasis reference standard in blood coagulation assays including Activated Clotting Time (ACT), Whole Blood Prothrombin Time (WBPT), Whole Blood Activated Partial Thromboplastin Time (WBAPTT) and Whole Blood Thrombin time (WBTT). Also disclosed are methods for determining the human standardized potency of heparin and protamine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6403381-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007254840-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7160540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8632771-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008004221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0203075-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6566140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0203075-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003211460-A1
priorityDate 1988-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4489162-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4250041-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4731330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4871677-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226431830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73896894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110

Total number of triples: 44.